OCTAPLAS
Biological
Octapharma USA, Inc.
Total Payments
$560,635
Transactions
439
Doctors
221
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5,000 | 1 | 1 |
| 2023 | $6,790 | 11 | 1 |
| 2022 | $1,433 | 15 | 13 |
| 2021 | $165.24 | 3 | 3 |
| 2020 | $70,829 | 46 | 37 |
| 2019 | $124,394 | 169 | 121 |
| 2018 | $134,788 | 93 | 58 |
| 2017 | $217,236 | 101 | 42 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $506,600 | 110 | 90.4% |
| Honoraria | $26,000 | 9 | 4.6% |
| Food and Beverage | $8,892 | 289 | 1.6% |
| Grant | $7,500 | 2 | 1.3% |
| Travel and Lodging | $7,031 | 26 | 1.3% |
| Consulting Fee | $4,612 | 3 | 0.8% |
Payments by Type
Research
$506,600
110 transactions
General
$54,035
329 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LAS-215 | Octapharma USA, Inc. | $176,936 | 3 |
| LAS-213 | Octapharma USA, Inc. | $161,157 | 5 |
| LAS-212 | Octapharma USA, Inc. | $86,005 | 4 |
| OCTAPLAS IIS STUDY | Octapharma USA, Inc. | $62,165 | 0 |
| LAS-214 | Octapharma USA, Inc. | $14,523 | 0 |
| LAS - 213 | Octapharma USA, Inc. | $5,815 | 0 |
Top Doctors Receiving Payments for OCTAPLAS — Page 7
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Houston, TX | $20.27 | 1 |
| , M.D | Anesthesiology | Houston, TX | $20.27 | 1 |
| , MD | Anesthesiology | Sugar Land, TX | $20.27 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Los Angeles, CA | $19.11 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Los Angeles, CA | $19.11 | 1 |
| , M.D | Hematology | Orlando, FL | $18.95 | 1 |
| , M.D | Internal Medicine | Orlando, FL | $18.95 | 1 |
| , M.D | Hematology & Oncology | Houston, TX | $18.69 | 1 |
| , M.D | Infectious Disease | Wyoming, MN | $17.15 | 1 |
| , M.D | Internal Medicine | Mankato, MN | $17.03 | 1 |
| , M.D | Nephrology | Milwaukee, WI | $16.63 | 1 |
| , MD | Hematology & Oncology | San Antonio, TX | $16.38 | 1 |
| , MD | Radiation Oncology | San Marcos, TX | $16.38 | 1 |
| , MD | Hematology & Oncology | New Braunfels, TX | $16.38 | 1 |
| , MD | Internal Medicine | New Braunfels, TX | $16.38 | 1 |
| , MD | Hematology & Oncology | Montclair, NJ | $16.31 | 1 |
| , MD | Internal Medicine | Grand Forks, ND | $15.73 | 1 |
| , M.D | Nephrology | Kearney, NE | $15.58 | 1 |
| Joan Graziano | — | Staten Island, NY | $15.07 | 1 |
| , M.D | Specialist | Staten Island, NY | $15.07 | 1 |
| , MD | Pediatrics | Ocala, FL | $15.05 | 1 |
| , M.D | Blood Banking & Transfusion Medicine | Houston, TX | $14.97 | 1 |
| , D.O | Anatomic Pathology & Clinical Pathology | Memphis, TN | $14.97 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Houston, TX | $14.96 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Houston, TX | $14.96 | 1 |
Ad
Manufacturing Companies
- Octapharma USA, Inc. $560,635
Product Information
- Type Biological
- Total Payments $560,635
- Total Doctors 221
- Transactions 439
About OCTAPLAS
OCTAPLAS is a biological associated with $560,635 in payments to 221 healthcare providers, recorded across 439 transactions in the CMS Open Payments database. The primary manufacturer is Octapharma USA, Inc..
Payment data is available from 2017 to 2024. In 2024, $5,000 was paid across 1 transactions to 1 doctors.
The most common payment nature for OCTAPLAS is "Unspecified" ($506,600, 90.4% of total).
OCTAPLAS is associated with 6 research studies, including "LAS-215" ($176,936).